Renaissance Technologies
INBS icon

Renaissance Technologies’s Intelligent Bio Solutions INBS Stock Holding History

Renaissance Technologies’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,090
Closed -$18.7K – 3692
2025
Q2 		$18.7K Buy
+1,090
New +$15.7K ﹤0.01% 3474
2024
Q1 		– Sell
-1,230
Closed -$50K – 3872
2023
Q4 		$50K Buy
+1,230
New +$48.3K ﹤0.01% 3458
2023
Q1 		– Sell
-44
Closed -$21K – 4175
2022
Q4 		$21K Sell
44
-1
-2% -$959 ﹤0.01% 3950
2022
Q3 		$45K Sell
45
-2
-4% -$3.03K ﹤0.01% 3782
2022
Q2 		$74K Buy
47
+19
+68% +$32K ﹤0.01% 3916
2022
Q1 		$53K Buy
+28
New +$64.4K ﹤0.01% 3902

Other funds holding INBS

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
CW
Curio Wealth Annapolis, Maryland $293M AUM 14.23% 1-Year Est. Return

Renaissance Technologies's INBS Position: Q3 2025 in Review

Renaissance Technologies sold out of Intelligent Bio Solutions (INBS) in Q3 2025, closing a stake of 1,090 shares — an estimated $18.7K sold.

Renaissance Technologies first reported a position in INBS in Q1 2022 and held it in 6 quarters. The position peaked at $74K in Q2 2022. 12 funds tracked by Wall St. Rank hold INBS as of Q3 2025.

  • Renaissance Technologies reported no remaining Intelligent Bio Solutions position as of Q3 2025 after selling out during the quarter.
  • Renaissance Technologies sold 1,090 Intelligent Bio Solutions shares in Q3 2025, an estimated $18.7K.
  • Renaissance Technologies first reported a position in Intelligent Bio Solutions in Q1 2022 and held it in 6 quarters.
  • Renaissance Technologies's Intelligent Bio Solutions position peaked at $74K in Q2 2022.
  • 12 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.